84 related articles for article (PubMed ID: 8957072)
1. Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation.
Mayo LD; Berberich SJ
Oncogene; 1996 Dec; 13(11):2315-21. PubMed ID: 8957072
[TBL] [Abstract][Full Text] [Related]
2. Constitutive mdmx expression during cell growth, differentiation, and DNA damage.
Jackson MW; Berberich SJ
DNA Cell Biol; 1999 Sep; 18(9):693-700. PubMed ID: 10492400
[TBL] [Abstract][Full Text] [Related]
3. DNA binding activities of p53 protein following cisplatin damage of ovarian cells.
Wetzel CC; Berberich SJ
Oncol Res; 1998; 10(3):151-61. PubMed ID: 9700726
[TBL] [Abstract][Full Text] [Related]
4. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53.
Mayo LD; Turchi JJ; Berberich SJ
Cancer Res; 1997 Nov; 57(22):5013-6. PubMed ID: 9371494
[TBL] [Abstract][Full Text] [Related]
5. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
[TBL] [Abstract][Full Text] [Related]
6. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J; Lin J; Levine AJ
Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
[TBL] [Abstract][Full Text] [Related]
7. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2.
Blaydes JP; Gire V; Rowson JM; Wynford-Thomas D
Oncogene; 1997 Apr; 14(15):1859-68. PubMed ID: 9150392
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
Whitman MM; Shen YM; Soprano D; Soprano KJ
Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
[TBL] [Abstract][Full Text] [Related]
9. The p53-mdm-2 autoregulatory feedback loop.
Wu X; Bayle JH; Olson D; Levine AJ
Genes Dev; 1993 Jul; 7(7A):1126-32. PubMed ID: 8319905
[TBL] [Abstract][Full Text] [Related]
10. mdm-2 gene amplification in 3T3-L1 preadipocytes.
Berberich SJ; Litteral V; Mayo LD; Tabesh D; Morris D
Differentiation; 1999 May; 64(4):205-12. PubMed ID: 10365438
[TBL] [Abstract][Full Text] [Related]
11. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
Olson DC; Marechal V; Momand J; Chen J; Romocki C; Levine AJ
Oncogene; 1993 Sep; 8(9):2353-60. PubMed ID: 7689721
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 and mdm-2 proteins in Hodgkin's Disease. Absence of correlation with the presence of Epstein-Barr virus.
Tzardi M; Kouvidou C; Panayiotides I; Koutsoubi K; Stefanaki K; Giannikaki E; Darivianaki K; Zois M; Eliopoulos G; Kakolyris S; Delides G; Rontogianni D; Kanavaros P
Anticancer Res; 1996; 16(5A):2813-9. PubMed ID: 8917390
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.
Momand J; Zambetti GP
Oncogene; 1996 Jun; 12(11):2279-89. PubMed ID: 8649767
[TBL] [Abstract][Full Text] [Related]
15. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
Landers JE; Cassel SL; George DL
Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029
[TBL] [Abstract][Full Text] [Related]
16. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53.
Otto A; Deppert W
Oncogene; 1993 Sep; 8(9):2591-603. PubMed ID: 8361769
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
19. DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells.
Price BD; Park SJ
Cancer Res; 1994 Feb; 54(4):896-9. PubMed ID: 8313378
[TBL] [Abstract][Full Text] [Related]
20. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
